Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : PNT2004
Therapeutic Area : Oncology
Study Phase : Preclinical
Sponsor : Point Biopharma
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : The agreement provides POINT the exclusive global rights to commercialize the groundbreaking can-SEEK™ tumor targeting technology. With canSEEK™, POINT expands its theragnostic oncology pipeline to include PNT2004, a pan tumor treatment.
Product Name : PNT2004
Product Type : Radiolabelled Compounds
Upfront Cash : Undisclosed
October 11, 2020
Lead Product(s) : PNT2004
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Sponsor : Point Biopharma
Deal Size : Undisclosed
Deal Type : Licensing Agreement